Technology I
Extracelluar Vesicles, EVs Production Technology
Large-Scale EVs Production, Purification, and Lyophilization.
We have developed an advanced ultrafiltration-based EVs enrichment technology, enabling large-scale EVs production with high purity and stability. This innovative approach enhances EVs yield while preserving their bioactivity, making them suitable for various therapeutic applications. Our proprietary purification and lyophilization processes ensure that the EVs remain bioactive, stable, and effective for long-term storage and clinical use.
This cutting-edge technology has been granted a Taiwan patent (Patent No. 202307204), titled "Exosome Enrichment by Ultrafiltration," reinforcing its significance in regenerative medicine, drug delivery, and clinical applications.
